Dr. Reddy's Laboratories, Inc.

Complete recall history across all FDA and CPSC categories — 163 total recalls

Dr. Reddy's Laboratories, Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (163)

FDA drug safety enforcement actions by Dr. Reddy's Laboratories, Inc.. Showing most recent 50.

Date Product Reason Class
Nov 11, 2025 Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Labor... Sub potent drug: during the 9-month stability test conducted, the assay value... Class III
Sep 26, 2025 Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL ... Out-of-Specification (OOS) result during the 6-month stability testing; decre... Class II
Jun 30, 2025 Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, M... Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium E... Class II
Mar 13, 2025 Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), ... LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetirace... Class I
Nov 22, 2024 Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx On... Failed Impurities/Degradation Specifications Class III
Oct 29, 2024 IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. ... Failed Tablet/Capsule Specifications Class III
Oct 22, 2024 Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only,... Failed Impurities/Degradation Specification Class II
Oct 22, 2024 Morphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx On... Failed Impurities/Degradation Specification Class II
Oct 9, 2024 Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommen... Class II
Oct 9, 2024 Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratorie... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommen... Class II
Oct 9, 2024 Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommen... Class II
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, w... Class II
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 400 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, w... Class II
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 800 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, w... Class II
Jun 26, 2024 Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets ... Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and ex... Class III
Jun 7, 2024 Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured... Presence of foreign substance. Class II
Jun 4, 2024 Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Redd... Failed Impurities/Degradation Specifications: Related Substances Class III
May 23, 2024 Zoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials... Lack of Assurance of Sterility: Leaking vials Class II
May 1, 2024 Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. ... Failed Impurities/Degradation Specifications Class III
Apr 8, 2024 Javygtor (sapropterin dihydrochloride) Powder for Oral Solution 100mg, 30 ind... Sub-potent Drug; powder discoloration associated with decreased potency Class I
Apr 8, 2024 Sapropterin Dihydrochloride Powder for Oral Solution 100mg, 30 individual pac... Sub-potent Drug; powder discoloration associated with decreased potency Class I
Jan 18, 2024 Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy'... Misprint on tablet Class III
Jan 18, 2024 Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy'... Misprint on tablet Class III
Jan 2, 2024 Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's ... Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets. Class II
Dec 15, 2023 Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr... Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in ... Class II
Oct 13, 2023 Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distribute... Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bot... Class II
Feb 8, 2023 Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Redd... Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule... Class II
Nov 21, 2022 Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 12... Failed dissolution specifications Class III
Sep 14, 2022 Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules ... Failed Stability Specifications: Out of specification results reported at 12-... Class III
Jul 13, 2022 Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count ... FAILED DISSOLUTION SPECIFICATIONS Class II
Jul 13, 2022 Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count ... FAILED DISSOLUTION SPECIFICATIONS Class II
Apr 15, 2022 Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs o... Failed Dissolution Specifications Class II
Mar 23, 2022 Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 5... Failed Dissolution Specifications; during long term stability testing. Class II
Mar 23, 2022 Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, ... Failed Dissolution Specifications; during long term stability testing. Class II
Mar 16, 2022 Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Re... Failed Impurities/Degradation Specifications: Out of Specification results fo... Class III
Feb 17, 2022 Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, 30 individual p... Subpotent Drug: Out-of-specification results observed in Assay in sapropterin... Class III
Jan 19, 2022 Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Labo... Failed stability specifications Class III
Jan 19, 2022 Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's ... Failed stability specifications Class III
Jan 19, 2022 Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's... Failed stability specifications Class III
Jan 10, 2022 Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, pack... Subpotent drug Class III
Jan 4, 2022 Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine... Failed Dissolution Specifications Class III
Jan 4, 2022 Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedr... Failed Dissolution Specifications Class III
Jan 4, 2022 Rite Aid Pharmacy, Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedr... Failed Dissolution Specifications Class III
Jan 4, 2022 Dr. Reddys, Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Rele... Failed Dissolution Specifications Class III
Jan 4, 2022 Wal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Na... Failed Dissolution Specifications Class III
Jan 4, 2022 Rugby, Antihistamine and Nasal Decongestant, Fexofenadine HCl 60mg and Pseudo... Failed Dissolution Specifications Class III
Jan 4, 2022 equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrin... Failed Dissolution Specifications Class III
Jan 4, 2022 CVS Health, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine Pseudoephe... Failed Dissolution Specifications Class III
Jan 4, 2022 QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Exten... Failed Dissolution Specifications Class III
Nov 12, 2021 Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Exten... Failed dissolution specifications Class III

View all 163 drug recalls →

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.